New York · 2025 Regular Session · Bill

A 11628: Requires insurance coverage for FDA approved expanded access to certain investigational medical products

In committee Last action July 29, 2026: REFERRED TO INSURANCE

Plain-language summary

A 11628 is a bill introduced in the New York House on July 29, 2026. According to its official title, it concerns: Requires insurance coverage for FDA approved expanded access to certain investigational medical products. Primary sponsor: Rules Committee. Most recent recorded action (July 29, 2026): REFERRED TO INSURANCE.

Sponsors

Primary sponsor: Rules Committee.